{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:28:38Z","timestamp":1794216518970,"version":"4.8.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["25cz020301-4803090"],"award-info":[{"award-number":["25cz020301-4803090"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["25cz020202-4803067"],"award-info":[{"award-number":["25cz020202-4803067"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["2021CR15"],"award-info":[{"award-number":["2021CR15"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jneuroim.2026.579071","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:41:13Z","timestamp":1786376473000},"page":"579071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rapid clinical stabilization following eculizumab therapy in severe anti-NMDAR encephalitis"],"prefix":"10.1016","volume":"421","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.579071_bb0005","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00134-024-07611-4","article-title":"Complement system activation: bridging physiology, pathophysiology, and therapy","volume":"50","author":"Azoulay","year":"2024","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5698\/1535-7597-14.3.127","article-title":"Paradox lost: exploring the clinical-radiologic dissociation seen in anti-NMDA receptor encephalitis","volume":"14","author":"Chang","year":"2014","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0015","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0020","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201603-0507OC","article-title":"Anti-N-methyl\u2011d-aspartate receptor encephalitis in adult patients requiring intensive care","volume":"195","author":"de Montmollin","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1557210","article-title":"Case report: efficacy of ofatumumab in refractory anti-NMDAR encephalitis: case series and literature review","volume":"16","author":"Deng","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0035","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/WNR.0000000000000851","article-title":"Persistence of parenchymal and perivascular T-cells in treatment-refractory anti-N-methyl-D-aspartate receptor encephalitis","volume":"28","author":"Filatenkov","year":"2017","journal-title":"Neuroreport"},{"key":"10.1016\/j.jneuroim.2026.579071_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2018.12.015","article-title":"EEG findings in NMDA encephalitis - a systematic review","volume":"65","author":"Gillinder","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.jneuroim.2026.579071_bb0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.molmed.2025.09.005","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis: insights and future treatment directions","volume":"32","author":"Hoshina","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0050","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(26)00087-6","article-title":"Therapeutic perspectives in refractory anti-NMDA receptor encephalitis","volume":"25","author":"Lee","year":"2026","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0060","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/acn3.51540","article-title":"The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis","volume":"9","author":"Lee","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0065","first-page":"251","article-title":"Neurocritical care for Anti-NMDA receptor encephalitis","volume":"43","author":"Lin","year":"2020","journal-title":"Biom. J."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0070","first-page":"e610","article-title":"Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension","volume":"96","author":"Mantegazza","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579071_bb0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579071_bb0080","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/brain\/awae410","article-title":"Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis","volume":"148","author":"Maudes","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2026.579071_bb0085","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in Aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0090","article-title":"Rituximab use for relapse prevention in anti-NMDAR antibody-mediated encephalitis: a multicenter cohort study","volume":"12","author":"Seery","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12028-021-01283-4","article-title":"Status epilepticus in patients with anti-NMDAR encephalitis requiring intensive care: a follow-up study","volume":"36","author":"Wang","year":"2021","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1163772","article-title":"Brain rhythmic abnormalities in convalescent patients with anti-NMDA receptor encephalitis: a resting-state EEG study","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579071_bb0110","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/acn3.51690","article-title":"Brain magnetic resonance imaging predictors in anti-N-methyl-D-aspartate receptor encephalitis","volume":"9","author":"Zhao","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:16:56Z","timestamp":1794215816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826002201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":22,"alternative-id":["S0165572826002201"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579071","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid clinical stabilization following eculizumab therapy in severe anti-NMDAR encephalitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"579071"}}